参考文献/References:
[1]Konyn P,Ahmed A,Kim D.Current epidemiology in hepatocellular carcinoma [J].Expert Rev Gastroenterol Hepatol,2021,15(11):1295-1307.[2]Kaibori M,Kon M,Kitawaki T,et al.Comparison of anatomic and non-anatomic hepatic resection for hepatocellular carcinoma [J].J Hepatobiliary Pancreat Sci,2017,24(11):616-626.[3]Cutolo C,Fusco R,Simonetti I,et al.Imaging Features of Main Hepatic Resections: The Radiologist Challenging [J].J Pers Med,2023,13(1):134.[4]A J,Zhang J,Chai J,et al.Comparison of the Efficacy of Anatomic and Non-anatomic Hepatectomy for Hepatic Alveolar Echinococcosis: Clinical Experience of 240 Cases in a Single Center [J].Front Public Health,2021,9:816704.[5]Liu J,Zhuang G,Bai S,et al.The Comparison of Surgical Margins and Type of Hepatic Resection for Hepatocellular Carcinoma With Microvascular Invasion [J].Oncologist,2023:oyad124.[6]Liu H,Hu FJ,Li H,et al.Anatomical vs nonanatomical liver resection for solitary hepatocellular carcinoma: A systematic review and meta-analysis [J].World J Gastrointest Oncol,2021,13(11):1833-1846.[7]Kaibori M,Matsui Y,Hijikawa T,et al.Comparison of limited and anatomic hepatic resection for hepatocellular carcinoma with hepatitis C [J].Surgery,2006,139(3):385-394.[8]Sato N,Marubashi S.What is the optimal surgical treatment for hepatocellular carcinoma beyond the debate between anatomical versus non-anatomical resection? [J].Surg Today,2022,52(6):871-880.[9]Liao K,Yang K,Cao L,et al.Laparoscopic Anatomical Versus Non-anatomical hepatectomy in the Treatment of Hepatocellular Carcinoma: A randomised controlled trial [J].Int J Surg,2022,102:106652.[10]Cazauran JB,Paris L,Rousset P,et al. Anatomy of the Right Anterior Sector of the Liver and Its Clinical Implications in Surgery [J].J Gastrointest Surg,2018,22(10):1819-1831.[11]戴朝六,赵闯,徐锋.国内外腹腔镜肝切除术相关指南解读与比较[J].中国实用外科杂志,2017,37(5):539-542.[12]Kang KJ,Ahn KS.Anatomical resection of hepatocellular carcinoma: A critical review of the procedure and its benefits on survival [J].World J Gastroenterol,2017,23(7):1139-1146.[13]Zhou JM,Zhou CY,Chen XP,et al.Anatomic resection improved the long-term outcome of hepatocellular carcinoma patients with microvascular invasion: A prospective cohort study [J].World J Gastrointest Oncol,2021,13(12):2190-2202.[14]Shindoh J,Kobayashi Y,Umino R,et al.Successful Anatomic Resection of Tumor-Bearing Portal Territory Delays Long-Term Stage Progression of Hepatocellular Carcinoma [J].Ann Surg Oncol,2021,28(2):844-853.[15]Jia CK,Weng J,Chen YK,et al.Anatomic resection of liver segments 6-8 for hepatocellular carcinoma [J].World J Gastroenterol,2014,20(15):4433-4439.[16]Kang WH,Kim KH,Jung DH,et al.Long-term results of laparoscopic liver resection for the primary treatment of hepatocellular carcinoma: role of the surgeon in anatomical resection [J].Surg Endosc,2018,32(11):4481-4490.[17]王锦祥,李晓辉,刘特彬,等.吲哚菁绿荧光融合影像引导在腹腔镜解剖性肝切除术中的应用研究[J].江西医药,2021,56(1):42-48.[18]Tomassini F,Scuderi V,Colman R,et al.The single surgeon learning curve of laparoscopic liver resection: A continuous evolving process through stepwise difficulties [J].Medicine (Baltimore),2016,95(43):e5138.[19]Yamamoto Y,Ikoma H,Morimura R,et al.Clinical analysis of anatomical resection for the treatment of hepatocellular carcinoma based on the stratification of liver function [J].World J Surg,2014,38(5):1154-1163.[20]牟晓峰,王毅军.精准肝切除时代下肝脏切面的选择[J].医学信息,2023,36(6):185-188.[21]Gavriilidis P,Edwin B,Pelanis E,et al.Navigated liver surgery: State of the art and future perspectives [J]. Hepatobiliary Pancreat Dis Int,2022,21(3):226-233.[22]Ye R,Xie Y,Zhong D,et al.Effect of digital three-dimensional reconstruction technique combined with indocyanine green (ICG) excretion test for precision hepatectomy in primary liver cancer [J].Am J Transl Res,2023,15(5):3511-3520.
相似文献/References:
[1]王利娜,赵雪梅,徐云霞,等.磁共振扩散张量成像在肝细胞癌及
肝转移瘤鉴别诊断价值研究[J].医学信息,2018,31(09):12.[doi:10.3969/j.issn.1006-1959.2018.09.004]
WANG Li-na,ZHAO Xue-mei,XU Yun-xia,et al.Diagnostic Value of Magnetic Resonance Diffusion Tensor Imaging in Hepatocellular Carcinoma and Liver Metastases[J].Journal of Medical Information,2018,31(12):12.[doi:10.3969/j.issn.1006-1959.2018.09.004]
[2]刘 冰,杨 帅,费锡斌,等.GPC-3联合CK-19免疫组化检测在肝细胞癌诊断及鉴别诊断中的应用[J].医学信息,2019,32(23):169.[doi:10.3969/j.issn.1006-1959.2019.23.054]
LIU Bing,YANG Shuai,FEI Xi-bin,et al.Application of GPC-3 Combined with CK-19 Immunohistochemical Detection in Diagnosis and Differential Diagnosis of Hepatocellular Carcinoma[J].Journal of Medical Information,2019,32(12):169.[doi:10.3969/j.issn.1006-1959.2019.23.054]
[3]刘丽丽.CLCVP对肝细胞癌行腹腔镜肝叶切除手术相关指标及肝门阻断时间的影响[J].医学信息,2020,33(19):88.[doi:10.3969/j.issn.1006-1959.2020.19.025]
LIU Li-li.The Effect of CLCVP on the Operation-related Indexes and Port Occlusion Time in Patients with Hepatocellular Carcinoma Undergoing Laparoscopic Lobectomy[J].Journal of Medical Information,2020,33(12):88.[doi:10.3969/j.issn.1006-1959.2020.19.025]
[4]孙莹莹,龚先琼.中药单体治疗肝细胞癌的研究[J].医学信息,2021,34(09):33.[doi:10.3969/j.issn.1006-1959.2021.09.008]
SUN Ying-ying,GONG Xian-qiong.Study on the Treatment of Hepatocellular Carcinoma with Chinese Medicine Monomer[J].Journal of Medical Information,2021,34(12):33.[doi:10.3969/j.issn.1006-1959.2021.09.008]
[5]林思其,张泽鑫,夏睿琪,等.三种miRNA对肝癌预后预测的生物信息学分析模型[J].医学信息,2022,35(03):81.[doi:10.3969/j.issn.1006-1959.2022.03.019]
LIN Si-qi,ZHANG Ze-xin,XIA Rui-qi,et al.A Model of Three miRNA on the Prognosis Prediction of Hepatocellular Carcinomaby Bioinformatics Analysis[J].Journal of Medical Information,2022,35(12):81.[doi:10.3969/j.issn.1006-1959.2022.03.019]
[6]李一鸣,陈文翔,王 禹,等.肝癌预后模型的构建及其在免疫治疗中的作用研究[J].医学信息,2022,35(04):68.[doi:10.3969/j.issn.1006-1959.2022.04.018]
LI Yi-ming,CHEN Wen-xiang,WANG Yu,et al.The Construction of a Prognostic Model for Hepatocellular Carcinomaand its Role in Immunotherapy[J].Journal of Medical Information,2022,35(12):68.[doi:10.3969/j.issn.1006-1959.2022.04.018]
[7]徐帅帅,高 斌.TACE与阿帕替尼联合治疗中晚期肝细胞癌的疗效及安全性分析[J].医学信息,2022,35(06):116.[doi:10.3969/j.issn.1006-1959.2022.06.028]
XU Shuai-shuai,GAO Bin.Analysis of the Efficacy and Safety of TACE Combined with Apatinib in the Treatment of Advanced Hepatocellular Carcinoma[J].Journal of Medical Information,2022,35(12):116.[doi:10.3969/j.issn.1006-1959.2022.06.028]
[8]李文华,许传斌,崔景景,等.基于治疗前MR-T2WI影像组学特征预测肝细胞癌射频消融术后早期复发的价值[J].医学信息,2022,35(18):39.[doi:10.3969/j.issn.1006-1959.2022.18.009]
LI Wen-hua,XU Chuan-bin,CUI Jing-jing,et al.The Value of Predicting Early Recurrence of Hepatocellular Carcinoma After Radiofrequency Ablation Based on Pre-treatment MR-T2WI Radiomics Features[J].Journal of Medical Information,2022,35(12):39.[doi:10.3969/j.issn.1006-1959.2022.18.009]
[9]彭莉蓉,黎村艳,史 杨.肿瘤微环境免疫细胞中差异lncRNA对肝细胞癌预后的预测价值[J].医学信息,2022,35(20):18.[doi:10.3969/j.issn.1006-1959.2022.20.005]
PENG Li-rong,LI Cun-yan,SHI Yang.The Predictive Value of Differential lncRNA in Tumor Microenvironment Immune Cells for the Prognosis of Hepatocellular Carcinoma[J].Journal of Medical Information,2022,35(12):18.[doi:10.3969/j.issn.1006-1959.2022.20.005]
[10]裴金仙,陈天狮,任巧晶,等.JAK2/STAT3通路在HBV相关肝细胞癌中表达及机制研究[J].医学信息,2022,35(24):59.[doi:10.3969/j.issn.1006-1959.2022.24.012]
PEI Jin-xian,CHEN Tian-shi,REN Qiao-jing,et al.The Expression and Mechanism of JAK2/STAT3 Pathway in HBV-related Hepatocellular Carcinoma[J].Journal of Medical Information,2022,35(12):59.[doi:10.3969/j.issn.1006-1959.2022.24.012]